BAIARDI, SIMONE
 Distribuzione geografica
Continente #
NA - Nord America 3.028
EU - Europa 2.412
AS - Asia 1.736
AF - Africa 76
SA - Sud America 44
OC - Oceania 5
Totale 7.301
Nazione #
US - Stati Uniti d'America 2.998
IT - Italia 841
CN - Cina 442
SG - Singapore 422
VN - Vietnam 390
GB - Regno Unito 351
DE - Germania 281
HK - Hong Kong 241
SE - Svezia 226
NL - Olanda 160
RU - Federazione Russa 105
IE - Irlanda 104
FR - Francia 89
IN - India 87
FI - Finlandia 63
KR - Corea 52
BG - Bulgaria 40
BR - Brasile 37
ZA - Sudafrica 34
ID - Indonesia 33
CI - Costa d'Avorio 31
JO - Giordania 26
UA - Ucraina 25
AT - Austria 24
EE - Estonia 22
CA - Canada 18
DK - Danimarca 16
BE - Belgio 11
CH - Svizzera 10
ES - Italia 10
MX - Messico 10
PL - Polonia 9
TR - Turchia 8
GR - Grecia 6
TG - Togo 6
JP - Giappone 5
UZ - Uzbekistan 5
AU - Australia 4
NG - Nigeria 4
BD - Bangladesh 3
EC - Ecuador 3
LB - Libano 3
LT - Lituania 3
LU - Lussemburgo 3
LV - Lettonia 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
CL - Cile 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
IR - Iran 2
MY - Malesia 2
RO - Romania 2
SA - Arabia Saudita 2
AM - Armenia 1
AZ - Azerbaigian 1
BZ - Belize 1
EG - Egitto 1
GE - Georgia 1
GT - Guatemala 1
IQ - Iraq 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TH - Thailandia 1
VE - Venezuela 1
Totale 7.301
Città #
Fairfield 359
Singapore 343
Southend 300
Chandler 289
Ashburn 244
Hong Kong 240
Bologna 223
Dong Ket 187
Woodbridge 173
Seattle 153
Houston 145
Cambridge 131
Wilmington 131
Dublin 104
Princeton 104
Santa Clara 102
Redmond 96
Ann Arbor 95
Hefei 92
Boardman 82
Turin 75
Seoul 52
Florence 43
Sofia 40
Berlin 39
Milan 39
Westminster 34
Jakarta 32
Abidjan 31
Imola 31
Ho Chi Minh City 30
Lappeenranta 29
Hanoi 28
Helsinki 28
Nanjing 27
Amman 26
New York 25
Nuremberg 24
Beijing 20
Boydton 20
Jinan 20
Padova 20
Rome 20
Frankfurt am Main 18
Los Angeles 17
San Diego 16
Amsterdam 15
Vienna 14
Falkenstein 13
Falls Church 13
Shenyang 13
Tongling 13
Guangzhou 12
Tianjin 12
Des Moines 11
Forlì 11
Munich 11
Brussels 10
Genoa 10
London 10
Phoenix 10
Shanghai 10
Yubileyny 10
Bergamo 9
Hebei 9
Olalla 9
Redwood City 9
Saint Petersburg 9
Toronto 9
Verona 9
Changsha 8
Dallas 8
Medford 8
Perugia 8
Trento 8
Bern 7
Mexico City 7
Monzuno 7
Ankara 6
Cesena 6
Chengdu 6
Chicago 6
Hangzhou 6
Lomé 6
Norwalk 6
Pune 6
Udine 6
Zhengzhou 6
Copenhagen 5
Haikou 5
L'Hospitalet de Llobregat 5
Mordano 5
Mountain View 5
Qingdao 5
Rodi Garganico 5
San Francisco 5
San Jose 5
Taizhou 5
The Dalles 5
Turku 5
Totale 4.819
Nome #
Cognitive rehabilitation and transcranial direct current stimulation in a patient with posterior cortical atrophy: An fMRI study 214
High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions 171
CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia 171
Chronobiology, sleep-related risk factors and light therapy in perinatal depression: The "Life-ON" project 165
Analysis of RNA Expression Profiles Identifies Dysregulated Vesicle Trafficking Pathways in Creutzfeldt-Jakob Disease 165
Atypical Creutzfeldt-Jakob disease with PrP-amyloid plaques in white matter: molecular characterization and transmission to bank voles show the M1 strain signature 155
A restless abdomen and propriospinal myoclonus like at sleep onset: an unusual overlap syndrome. 154
Cataplectic attacks during rapid eye movement sleep behavior disorder episodes in a narcoleptic patient. 153
Clinical Reasoning: Rapidly progressive dementia in a patient with HIV after an exotic journey 150
Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and A$\upbeta$42 levels 147
Cerebrospinal fluid biomarkers of neurodegeneration in narcolepsy type 1 141
Two novel PRNP truncating mutations broaden the spectrum of prion amyloidosis 140
Characterization of novel progranulin gene variants in Italian patients with neurodegenerative diseases 140
Identification of rare genetic variants in Italian patients with dementia by targeted gene sequencing 139
Detection of prions in skin punch biopsies of Creutzfeldt–Jakob disease patients 135
The characterization of AD/PART co-pathology in CJD suggests independent pathogenic mechanisms and no cross-seeding between misfolded Aβ and prion proteins 129
Neurofilament light chain and α-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes 126
Sporadic Fatal Insomnia in Europe: Phenotypic features and diagnostic challenges 125
Comparison between plasma and cerebrospinal fluid biomarkers for the early diagnosis and association with survival in prion disease 121
Revisiting the Heidenhain Variant of Creutzfeldt-Jakob Disease: Evidence for Prion Type Variability Influencing Clinical Course and Laboratory Findings 120
Antemortem CSF Aβ42/Aβ40 ratio predicts Alzheimer's disease pathology better than Aβ42 in rapidly progressive dementias 118
Towards an early clinical diagnosis of sporadic CJD VV2 (ataxic type) 117
Clinicopathological features of the rare form of Creutzfeldt-Jakob disease in R208H-V129V PRNP carrier 114
Narcolepsy Type 1 and Idiopathic Generalized Epilepsy: Diagnostic and Therapeutic Challenges in Dual Cases 113
Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden 112
Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies 111
Identification of recurrent genetic patterns from targeted sequencing panels with advanced data science: a case-study on sporadic and genetic neurodegenerative diseases 109
Unusual Clinical Presentations Challenging the Early Clinical Diagnosis of Creutzfeldt-Jakob Disease 108
Is the Epworth Sleepiness Scale a useful tool for screening excessive daytime sleepiness in commercial drivers? 106
null 103
Immunotherapy of oneiric stupor in Morvan syndrome: Efficacy documented by actigraphy 100
Towards an improved early diagnosis of neurodegenerative diseases: The emerging role of in vitro conversion assays for protein amyloids 97
null 96
Cognitive profile in idiopathic autonomic failure: relation with white matter hyperintensities and neurofilament levels 94
Sleep-readiness signals in insomniacs and good sleepers 93
Remitting Tics and Narcolepsy Overlap Associated with Streptococcal Infection: A Case Report 93
In vivo assessment of Lewy body and beta-amyloid copathologies in idiopathic normal pressure hydrocephalus: prevalence and associations with clinical features and surgery outcome 91
Understanding prion strains: Evidence from studies of the disease forms affecting humans 91
On the road for a single and reliable objective assessment of sleepiness. 90
Recent advances in the histo-molecular pathology of human prion disease 89
Prion-related peripheral neuropathy in sporadic Creutzfeldt-Jakob disease 88
Diagnostic value of surrogate CSF biomarkers for Creutzfeldt–Jakob disease in the era of RT-QuIC 84
Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias 83
Phenotypic Heterogeneity of Variably Protease-Sensitive Prionopathy: A Report of Three Cases Carrying Different Genotypes at PRNP Codon 129 83
Clinical effects of Lewy body pathology in cognitively impaired individuals 82
Csf ubiquitin levels are higher in alzheimer’s disease than in frontotemporal dementia and reflect the molecular subtype in prion disease 81
RT-QuIC Detection of Pathological α-Synuclein in Skin Punches of Patients with Lewy Body Disease 79
Elevated plasma p-tau181 levels unrelated to Alzheimer's disease pathology in amyotrophic lateral sclerosis 76
CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson’s disease 75
Diagnostic Value of the CSF α-Synuclein Real-Time Quaking-Induced Conversion Assay at the Prodromal MCI Stage of Dementia With Lewy Bodies 75
Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson’s disease and dementia with Lewy bodies 73
Validation of Revised International Creutzfeldt-Jakob Disease Surveillance Network Diagnostic Criteria for Sporadic Creutzfeldt-Jakob Disease 72
Genomic, transcriptomic and RNA editing analysis of human MM1 and VV2 sporadic Creutzfeldt-Jakob disease 71
α-Synuclein RT-QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies 69
Multiple variants in families with amyotrophic lateral sclerosis and frontotemporal dementia related to C9orf72 repeat expansion: further observations on their oligogenic nature 65
Cognitive effects of Lewy body pathology in clinically unimpaired individuals 65
Dementia-related genetic variants in an Italian population of early-onset Alzheimer’s disease 64
Diagnostic and prognostic performance of CSF α-synuclein in prion disease in the context of rapidly progressive dementia 62
Levels of plasma brain‐derived tau and p‐tau181 in Alzheimer's disease and rapidly progressive dementias 62
Amyloid-Beta Co-Pathology Is a Major Determinant of the Elevated Plasma GFAP Values in Amyotrophic Lateral Sclerosis 61
Prodynorphin and Proenkephalin in Cerebrospinal Fluid of Sporadic Creutzfeldt–Jakob Disease 59
Gerstmann-Straüssler-Scheinker disease (PRNP p.D202N) presenting with atypical parkinsonism 59
Survival of dialysis patients with restless legs syndrome: A 15-year follow-up study 56
Phenotypic diversity of genetic Creutzfeldt–Jakob disease: a histo-molecular-based classification 56
The In Vivo Diagnosis of Concomitant Alzheimer and Lewy Body Pathology: A Case Report 55
Sporadic Creutzfeldt-Jakob disease VM1: phenotypic and molecular characterization of a novel subtype of human prion disease 51
Human prion disease: molecular pathogenesis, and possible therapeutic targets and strategies 45
Diagnostic and prognostic value of cerebrospinal fluid SNAP-25 and neurogranin in Creutzfeldt-Jakob disease in a clinical setting cohort of rapidly progressive dementias 45
Influence of chronotype on the incidence and severity of perinatal depression in the "Life-ON" study 40
Depressive Symptoms and Amyloid Pathology 40
Defining the phenotypic spectrum of sporadic Creutzfeldt–Jakob disease MV2K: the kuru plaque type 39
Rapidly progressive dementia due to intravascular lymphoma: A prion disease reference center experience 38
High diagnostic performance of plasma and cerebrospinal fluid beta‐synuclein for sporadic Creutzfeldt–Jakob disease 35
Evaluation of the impact of CSF prion RT-QuIC and amended criteria on the clinical diagnosis of Creutzfeldt-Jakob disease: a 10-year study in Italy 34
Sleep and sleep disorders during pregnancy and postpartum: The Life-ON study 33
Technique and Preliminary Analysis of Drug-Induced Sleep Endoscopy With Online Polygraphic Cardiorespiratory Monitoring in Patients With Obstructive Sleep Apnea Syndrome. 31
null 29
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum 29
The Use of Real-Time Quaking-Induced Conversion for the Diagnosis of Human Prion Diseases 28
Alpha-synuclein seed amplification assay longitudinal outcomes in Lewy body disease spectrum 27
Misfolded α-Synuclein Assessment in the Skin and CSF by RT-QuIC in Isolated REM Sleep Behavior Disorder 27
Improving protocols for α-synuclein seed amplification assays: analysis of preanalytical and analytical variables and identification of candidate parameters for seed quantification 26
Diagnostic and Prognostic Value of Plasma GFAP in Sporadic Creutzfeldt-Jakob Disease in the Clinical Setting of Rapidly Progressive Dementia 24
Clinical value of novel blood-based tau biomarkers in Creutzfeldt–Jakob disease 24
A quantitative Lewy-fold-specific alpha-synuclein seed amplification assay as a progression marker for Parkinson's disease 24
Alpha-synuclein RT-QuIC assay in gastroduodenal and skin biopsies of Parkinson disease patients 23
Early onset sleep disorders predict severity, progression and death in multiple system atrophy 21
CSF markers of neurodegeneration Alzheimer's and Lewy body pathology in isolated REM sleep behavior disorder 17
Clinical, neuropathological, and molecular characteristics of rapidly progressive dementia with Lewy bodies: a distinct clinicopathological entity? 17
Unsuccessful transmissions of atypical genetic Creutzfeldt-Jakob disease (PRNP p.T183A-129M) in transgenic mice 16
α-Synuclein seed amplification assay detects Lewy body co-pathology in autosomal dominant Alzheimer's disease late in the disease course and dependent on Lewy pathology burden 16
Perspectives Toward the Development of Quantitative Seed Amplification Assays for α-Synuclein 14
In vivo detection of Alzheimer's and Lewy body disease concurrence: Clinical implications and future perspectives 13
Inside the clinical evaluation of sleepiness: subjective and objective tools 13
MRI Signature of α-Synuclein Pathology in Asymptomatic Stages and a Memory Clinic Population 13
Reactive microglia partially envelop viable neurons in prion diseases 12
Role of Blood P-Tau Isoforms (181, 217, 231) in Predicting Conversion from MCI to Dementia Due to Alzheimer's Disease: A Review and Meta-Analysis 11
PrP proteinopathies 8
Posterior hippocampal stroke presenting with transient global amnesia 6
Totale 7.630
Categoria #
all - tutte 25.476
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.476


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021890 97 49 10 20 21 39 70 86 83 44 28 343
2021/20221.033 55 35 48 35 113 44 16 120 63 95 212 197
2022/20231.317 117 147 62 130 119 107 54 62 233 48 153 85
2023/2024589 18 66 47 69 56 82 16 71 26 60 49 29
2024/20252.296 102 227 172 129 222 123 204 79 61 246 173 558
2025/202676 76 0 0 0 0 0 0 0 0 0 0 0
Totale 7.630